Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
J Sci Food Agric ; 95(4): 739-44, 2015 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-25042995

RESUMO

BACKGROUND: The root bark of Aralia is a rich source of bioactive components that may improve glycemic control and lipid status. In this study, 148 patients with type 2 diabetes mellitus (T2DM) were assigned randomly to receive either glipizide alone or glipizide plus Aralia root bark extract (ARBE) for 8 weeks to test the effects of ARBE plus glipizide therapy on glycemic control and lipid profiles in these patients. RESULTS: Levels of HbA1c, fasting plasma glucose (FPG) and 2 h postprandial plasma glucose (2-h PPG) in both groups significantly decreased from baseline. Glycated hemoglobin (HbA1c) decreased marginally significantly in participants taking glipizide plus ARBE compared with the glipizide group (P = 0.06). Participants in the combination group had significant decreases in total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C), and the between-group difference achieved statistical significance for LDL-C (P = 0.04). Reduction in HbA1c in the combination group was significantly associated with changes in TC (r = 0.32; P = 0.006) and LDL-C (r = 0.34; P = 0.005), and the change in FPG was inversely correlated with LDL-C reduction (r = 0.34; P = 0.004). CONCLUSIONS: In patients with T2DM, combination therapy with glipizide and ARBE resulted in moderately lowering HbA1c and LDL-C levels compared with glipizide alone.


Assuntos
Antioxidantes/uso terapêutico , Aralia/química , Diabetes Mellitus Tipo 2/dietoterapia , Suplementos Nutricionais , Hipolipemiantes/uso terapêutico , Casca de Planta/química , Extratos Vegetais/uso terapêutico , Antioxidantes/efeitos adversos , China , Terapia Combinada/efeitos adversos , Diabetes Mellitus Tipo 2/sangue , Diabetes Mellitus Tipo 2/complicações , Diabetes Mellitus Tipo 2/tratamento farmacológico , Suplementos Nutricionais/efeitos adversos , Método Duplo-Cego , Feminino , Glipizida/uso terapêutico , Humanos , Hiperglicemia/prevenção & controle , Hiperlipidemias/complicações , Hiperlipidemias/prevenção & controle , Hipoglicemiantes/uso terapêutico , Hipolipemiantes/efeitos adversos , Análise de Intenção de Tratamento , Perda de Seguimento , Masculino , Pessoa de Meia-Idade , Pacientes Desistentes do Tratamento , Extratos Vegetais/efeitos adversos
2.
Nutrients ; 6(1): 452-65, 2014 Jan 22.
Artigo em Inglês | MEDLINE | ID: mdl-24451312

RESUMO

The purpose of this meta-analysis was to evaluate the relationship between blood lutein and zeaxanthin concentration and the risk of age-related cataract (ARC). MEDLINE, EMBASE, ISI and Cochrane Library were searched to identify relevant studies up to April 2013. Meta-analysis was conducted to obtain pooled relative risks (RRs) for the highest-versus-lowest categories of blood lutein and zeaxanthin concentrations. One cohort study and seven cross-sectional studies were included in the meta-analysis. There were significant inverse associations between nuclear cataract and blood lutein and zeaxanthin concentrations, with the pooled RRs ranging from 0.63 (95% confidence interval (CI): 0.49, 0.77) for zeaxanthin to 0.73 (95% CI: 0.59, 0.87) for lutein. A stronger association between nuclear cataract and blood zeaxanthin might be noted for the studies conducted in the European Nations. Blood lutein and zeaxanthin were also noted to lead towards a decrease in the risk of cortical cataract and subcapsular cataract; however, these pooled RRs were not statistically significant, with the exception of a marginal association between lutein and subcapsular cataract. Our results suggest that high blood lutein and zeaxanthin are significantly associated with a decrease in the risk of nuclear cataract. However, no significant associations were found for ARC in other regions of the lens.


Assuntos
Catarata/sangue , Luteína/sangue , Estado Nutricional , Xantofilas/sangue , Humanos , Luteína/administração & dosagem , Estudos Observacionais como Assunto , Fatores de Risco , Xantofilas/administração & dosagem , Zeaxantinas
3.
Int J Ophthalmol ; 6(5): 718-22, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24195055

RESUMO

AIM: To determine the prevalence of asthenopia and identify any associated risk factors in the college students in Xi'an, China. METHODS: From April to September 2012, 1 500 students from five universities in Xi'an were selected according to a multi-stage stratified cluster sampling method. Data on demographic features, lifestyle or dietary habits, health status, living environment conditions, sleep and mental status, and asthenopia symptoms were collected through a self-administered validated questionnaire. Univariate logistic regression and multivariate logistic regression analysis modified by the factor analysis were performed to evaluate risk factors for asthenopia. RESULTS: Fifty-seven percent of the college students complained of asthenopia. Statistically significant risk factors for asthenopia in the univariate analysis included 13 variables. Multivariate analysis revealed a significant relationship between the use of computer and asthenopia (OR 1.21, 95%CI: 1.09 to 1.35). Good sleep and mental status (OR 0.86, 95%CI: 0.76 to 0.97), good living environment conditions (OR 0.67, 95%CI: 0.60 to 0.76), and high intake of green leafy vegetables (OR 0.89, 95%CI: 0.80 to 0.98) were found to be strong predictors of decreasing the occurrence of asthenopia complaints. CONCLUSION: Asthenopia symptom appears to be common among college students; and it is strongly associated with computer use, psychosocial state, environment conditions and dietary habits, suggesting that additional studies are warranted to verify these risk factors and establish prevention guidelines, especially for college students.

4.
Ophthalmic Genet ; 33(3): 171-8, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22809227

RESUMO

PURPOSE: To investigate whether the PAX6, Lumican, and MYOC genes are related to high myopia in Han Chinese since the association between these genes and high myopia is unclear in this patient population. METHODS: Peripheral venous blood samples were collected for DNA extraction from 220 subjects with high myopia (refractive error ≤-10.00 D) vs. normal controls among the Han Chinese of Northeastern China. Mass spectrometry was applied to detect 10 SNP loci of the PAX6, Lumican, and MYOC genes. The candidate region was analyzed using case-control correlation analysis. The χ(2) test was used to analyze the allele and genotype frequencies in the myopic group vs. the control group. Haploview software was used for haplotype analysis. RESULTS: The χ(2) test was used to compare the allele and genotype frequencies of SNPs in patients and control subjects and the results showed that ten SNPs of the PAX6, Lumican, and MYOC genes were not significantly associated with high myopia. CONCLUSIONS: Our results confirm that the PAX6, Lumican, and MYOC genes were not associated with high myopia in the Han Chinese in Northeastern China.


Assuntos
Proteoglicanas de Sulfatos de Condroitina/genética , Proteínas do Citoesqueleto/genética , Proteínas do Olho/genética , Glicoproteínas/genética , Proteínas de Homeodomínio/genética , Sulfato de Queratano/genética , Miopia Degenerativa/genética , Fatores de Transcrição Box Pareados/genética , Polimorfismo de Nucleotídeo Único , Proteínas Repressoras/genética , Povo Asiático/genética , Estudos de Casos e Controles , Frequência do Gene , Estudos de Associação Genética , Genótipo , Humanos , Lumicana , Espectrometria de Massas , Fator de Transcrição PAX6
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa